Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
34.80
+1.16 (3.45%)
Mar 6, 2026, 4:00 PM EST
5.87%
Market Cap 4.68B
Revenue (ttm) 422.03M
Net Income (ttm) 146.04M
Shares Out 134.87M
EPS (ttm) 1.07
PE Ratio 32.46
Forward PE 27.56
Dividend 0.56 (1.61%)
Ex-Dividend Date n/a
Volume 1,276,930
Average Volume 1,570,752
Open 33.30
Previous Close 33.64
Day's Range 33.30 - 34.89
52-Week Range 27.56 - 40.00
Beta 1.00
RSI 49.15
Earnings Date Apr 28, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 558
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 146.04 million, a decrease of -40.84%.

Financial Statements

News

There is no news available yet.